Who We Are

About Vanigent


Trusted Contract Sales Organization


Decades of pharmaceutical experience across the value chain


Successful implementation in commercial operations and drug development


Industry leading consultants

About Us

Committed to Performance

VANIGENT was founded in 2021, but we’re not new to the pharmaceutical and biotech industries. Our leadership team members have an average of 25 years’ experience building and managing specialized teams, including product sales, commercial operations, drug development, and portfolio commercialization. Our systematic approach merges your requirements and customer needs to curate best-in-class solutions to your unique product challenges. All solutions are built with integrity and ethics at the center.

The marketplace is ever-evolving and more competitive than ever. With our creative and disciplined team’s combination of tenure and diverse backgrounds, we deliver innovative, measurable, and results-driven outcomes that prioritize the needs of your organization and customers.

Committed to Excellence

Leadership Team

Javan Collins

Chief Executive Officer

Javan is the Chief Executive Officer of VANIGENT BioPharm and Chairman of the VANIGENT Corporation Board of Directors.

Javan brings unique executive expertise in leading commercial operations and clinical drug development at Eli Lilly and Company. He also has been a successful entrepreneur that has consistently demonstrated top business performance as a business owner and across marketing, sales, commercial operations, strategic planning, clinical drug development and business development. Javan has successfully launched products, turned around product performance, and led drug development through FDA Advisory Committee and global product approval.

Javan earned a B.S. in Pharmacy from University of Connecticut, and a M.B.A. from Columbia University.

Javan is married with two children and currently resides in Atlanta, Georgia.

Grady Grant, III

Executive Vice President / Partner

Grady has over 30 years experience in major pharmaceutical sales, sales operations, and marketing. He served as VP of sales for Eli Lilly and Company leading sales teams through multiple therapeutic markets, business reorganizations and key strategic partnerships. Following his tenure at Eli Lilly, he was VP of sales for Mead Johnson Nutrition, whose business model is a unique blend of strategy for medical and the consumer marketplace. Grady currently serves on the public board of Aptevo Therapeutics.

Grady is a graduate of Temple University School of Pharmacy, and has a General Management certification from Duke University’s Executive Education Program. He has completed training on Corporate Governance at Northwestern University’s Kellogg School of Management and has his NACD Directorship Certification.

Grady is married with two children and currently resides in Atlanta, Georgia.

Jim Seeds

Sr. Director of Sales Operations

Jim retired from Eli Lilly and Company in 2013 after a 30-year career in sales and marketing. His experiences include roles in sample accountability, sales force strategy and planning, brand marketing, incentive compensation and business reporting, sales leadership, commercial operations and business unit operations. In addition to his time at Lilly, he started his own sales force operations consulting business consulting for a top 10 pharmaceutical company and a Fortune 200 company.

From inception to sunsetting a sales organization Jim brings the experience needed to successfully scale, implement, and drive organizational performance.

Jim graduated from Butler University with a BS in Pharmacy. He is co-founder and serves as Board Chair of Circle City Fellows, a 501c3 non-profit in Indianapolis focused on helping young and older adults find their next right step to help Indianapolis flourish. Jim is married with 8 children and currently resides in Carmel, Indiana.

Troy Stribling Sr.

National Business Director

Troy brings over 25 years experience in senior leadership roles, leading sales organizations, as well as broad cross-functional experience in sales operations, market access and sales planning. He served in various roles at Merck & Co., promoting many commercially successful pharma brands across key strategic functions and therapeutic areas. He was Head of Sales for Teva Pharmaceuticals, leading their CNS/Specialty sales division. Troy was also Vice President, Commercial Sales for Aimmune Therapeutics. During his tenure he led the re-design, restructure, and corporate reorganization strategy for the commercial organization.

Troy is a graduate of Drexel University, Philadelphia, PA earning a Bachelor of Science in Business Administration. Troy continued his studies, receiving his MBA from the University of Phoenix, Philadelphia, Pennsylvania and Certificate of Professional Leadership from University of Pennsylvania – Wharton School of Business.

Troy is married with three children and currently resides in Florida.

Solutions You Can Trust

Committed to Our Values

Customer-centered signature solutions

With every decision we make, we seek to understand patient and caregiver needs and deliver executable, profitable solutions.

Accountable to our measurable outcomes

Our team’s combination of tenure and agile frameworks delivers innovative, measurable, and results-driven outcomes that prioritize the needs of your organization and customers.

Results-oriented & integrated strategies

Our integrated approach prioritizes execution, customer service, and sales performance. Your success is our success!

Ethics, excellence, & integrity

Integrity is a central value and a non-negotiable requirement. Operating compliantly and with integrity is required and everyone is accountable.

How We’re Giving Back

Committed to Community

VANIGENT team members are encouraged to volunteer and participate in community service projects. They also help decide where charitable contributions are made.